BLAST PHASE MYELOPROLIFERATIVE NEOPLASM

Clinical trials for BLAST PHASE MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new BLAST PHASE MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for BLAST PHASE MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental combo for rare blood cancer shows promise but trial halted early

Disease control Terminated

This early-phase trial tested a combination of two drugs—ruxolitinib and CPX-351—in 12 people with advanced myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The goal was to find the best dose and see if the combo could shrink cancer. However, the study was stop…

Matched conditions: BLAST PHASE MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 23, 2026 12:00 UTC

BLAST PHASE MYELOPROLIFERATIVE NEOPLASM

Get alerted when new BLAST PHASE MYELOPROLIFERATIVE NEOPLASM trials appear

Experimental combo for rare blood cancer shows promise but trial halted early